Lenington Rachel 4
4 · Athira Pharma, Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Lenington Rachel
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+180,000→ 180,000 totalExercise: $10.64Exp: 2032-01-17→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.